Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis

2.

Filipovich

AH

,

Chandrakasan

S

.

Pathogenesis of hemophagocytic lymphohistiocytosis

.

Hematol Oncol Clin North Am

.

2015

;

29

(

5

):

895

-

902

.

3.

Marsh

RA

,

Madden

L

,

Kitchen

BJ

, et al.

XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease

.

Blood

.

2010

;

116

(

7

):

1079

-

1082

.

4.

Romberg

N

,

Vogel

TP

,

Canna

SW

.

NLRC4 inflammasomopathies

.

Curr Opin Allergy Clin Immunol

.

2017

;

17

(

6

):

398

-

404

.

5.

Jordan

MB

,

Hildeman

D

,

Kappler

J

,

Marrack

P

.

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8⁺ T cells and interferon gamma are essential for the disorder

.

Blood

.

2004

;

104

(

3

):

735

-

743

.

6.

Das

R

,

Guan

P

,

Sprague

L

, et al.

Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis

.

Blood

.

2016

;

127

(

13

):

1666

-

1675

.

7.

Albeituni

S

,

Verbist

KC

,

Tedrick

PE

, et al.

Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis

.

Blood

.

2019

;

134

(

2

):

147

-

159

.

8.

Locatelli

F

,

Jordan

MB

,

Allen

C

, et al.

Emapalumab in children with primary hemophagocytic lymphohistiocytosis

.

N Engl J Med

.

2020

;

382

(

19

):

1811

-

1822

.

9.

De Benedetti

F

,

Grom

A

,

Brogan

P

, et al.

Efficacy and safety of emapalumab in macrophage activation syndrome

.

Ann Rheum Dis

.

2023

;

82

(

6

):

857

-

865

.

10.

Keenan

C

,

Nichols

KE

,

Albeituni

S

.

Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis

.

Front Immunol

.

2021

;

12

:

614704

.

11.

Pagel

J

,

Beutel

K

,

Lehmberg

K

, et al.

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

.

Blood

.

2012

;

119

(

25

):

6016

-

6024

.

12.

Meeths

M

,

Entesarian

M

,

Al-Herz

W

, et al.

Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2

.

Blood

.

2010

;

116

(

15

):

2635

-

2643

.

13.

Rohr

J

,

Beutel

K

,

Maul-Pavicic

A

, et al.

Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases

.

Haematologica

.

2010

;

95

(

12

):

2080

-

2087

.

14.

Esmaeilzadeh

H

,

Bemanian

MH

,

Nabavi

M

, et al.

Novel patient with late-onset familial hemophagocytic lymphohistiocytosis with STXBP2 mutations presenting with autoimmune hepatitis, neurological manifestations and infections associated with hypogammaglobulinemia

.

J Clin Immunol

.

2015

;

35

(

1

):

22

-

25

.

15.

Pachlopnik Schmid

J

,

Canioni

D

,

Moshous

D

, et al.

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)

.

Blood

.

2011

;

117

(

5

):

1522

-

1529

.

16.

Pieper

K

,

Grimbacher

B

,

Eibel

H

.

B-cell biology and development

.

J Allergy Clin Immunol

.

2013

;

131

(

4

):

959

-

971

.

17.

Lounder

DT

,

Bin

Q

,

de Min

C

,

Jordan

MB

.

Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections

.

Blood Adv

.

2019

;

3

(

1

):

47

-

50

.

18.

LeBien

TW

,

Tedder

TF

.

B lymphocytes: how they develop and function

.

Blood

.

2008

;

112

(

5

):

1570

-

1580

.

19.

Miosge

LA

,

Goodnow

CC

.

Genes, pathways and checkpoints in lymphocyte development and homeostasis

.

Immunol Cell Biol

.

2005

;

83

(

4

):

318

-

335

.

20.

Carulli

G

,

Ottaviano

V

,

Guerri

V

, et al.

Multiparameter flow cytometry to detect hematogones and to assess B-lymphocyte clonality in bone marrow samples from patients with non-Hodgkin lymphomas

.

Hematol Rep

.

2014

;

6

(

2

):

5381

.

21.

McKenna

RW

,

Washington

LT

,

Aquino

DB

,

Picker

LJ

,

Kroft

SH

.

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry

.

Blood

.

2001

;

98

(

8

):

2498

-

2507

.

22.

Sanz

I

,

Wei

C

,

Jenks

SA

, et al.

Challenges and opportunities for consistent classification of human B cell and plasma cell populations

.

Front Immunol

.

2019

;

10

:

2458

.

23.

Corcione

A

,

Benvenuto

F

,

Ferretti

E

, et al.

Human mesenchymal stem cells modulate B-cell functions

.

Blood

.

2006

;

107

(

1

):

367

-

372

.

24.

Ravelli

A

,

Minoia

F

,

Davi

S

, et al.

2016 classification criteria for macrophage activation syndrome complicating systemic Juvenile idiopathic arthritis: a European League against rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

.

Ann Rheum Dis

.

2016

;

75

(

3

):

481

-

489

.

25.

Henter

JI

,

Horne

A

,

Arico

M

, et al.

HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

.

Pediatr Blood Cancer

.

2007

;

48

(

2

):

124

-

131

.

26.

Chantepie

SP

,

Cornet

E

,

Salaun

V

,

Reman

O

.

Hematogones: an overview

.

Leuk Res

.

2013

;

37

(

11

):

1404

-

1411

.

27.

Roy

S

,

Guler

R

,

Parihar

SP

, et al.

Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection

.

J Immunol

.

2015

;

194

(

12

):

6035

-

6044

.

28.

Liu

M

,

Guo

S

,

Hibbert

JM

, et al.

CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications

.

Cytokine Growth Factor Rev

.

2011

;

22

(

3

):

121

-

130

.

29.

Honkala

AT

,

Tailor

D

,

Malhotra

SV

.

Guanylate-binding protein 1: an emerging target in inflammation and cancer

.

Front Immunol

.

2019

;

10

:

3139

.

30.

Farrar

MA

,

Schreiber

RD

.

The molecular cell biology of interferon-gamma and its receptor

.

Annu Rev Immunol

.

1993

;

11

:

571

-

611

.

31.

Halloran

PF

,

Miller

LW

,

Urmson

J

, et al.

IFN-gamma alters the pathology of graft rejection: protection from early necrosis

.

J Immunol

.

2001

;

166

(

12

):

7072

-

7081

.

32.

Havenar-Daughton

C

,

Lindqvist

M

,

Heit

A

, et al.

CXCL13 is a plasma biomarker of germinal center activity

.

Proc Natl Acad Sci U S A

.

2016

;

113

(

10

):

2702

-

2707

.

33.

Kumar

D

,

Rostad

CA

,

Jaggi

P

, et al.

Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)

.

J Allergy Clin Immunol

.

2022

;

149

(

5

):

1592

-

1606.e16

.

34.

Weiss

ES

,

Girard-Guyonvarc'h

C

,

Holzinger

D

, et al.

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

.

Blood

.

2018

;

131

(

13

):

1442

-

1455

.

35.

Papadaki

HA

,

Kritikos

HD

,

Gemetzi

C

, et al.

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect

.

Blood

.

2002

;

99

(

5

):

1610

-

1619

.

36.

Baratono

SR

,

Chu

N

,

Richman

LP

,

Behrens

EM

.

Toll-like receptor 9 and interferon-gamma receptor signaling suppress the B-cell fate of uncommitted progenitors in mice

.

Eur J Immunol

.

2015

;

45

(

5

):

1313

-

1325

.

37.

Yamada

G

,

Ogawa

M

,

Akagi

K

, et al.

Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice

.

Proc Natl Acad Sci U S A

.

1991

;

88

(

2

):

532

-

536

.

38.

Young

HA

,

Klinman

DM

,

Reynolds

DA

, et al.

Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies

.

Blood

.

1997

;

89

(

2

):

583

-

595

.

39.

Popescu

M

,

Cabrera-Martinez

B

,

Winslow

GM

.

TNF-alpha contributes to lymphoid tissue disorganization and germinal center B cell suppression during intracellular bacterial infection

.

J Immunol

.

2019

;

203

(

9

):

2415

-

2424

.

40.

Borte

S

,

Meeths

M

,

Liebscher

I

, et al.

Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies

.

J Allergy Clin Immunol

.

2014

;

134

(

1

):

226

-

228

.

41.

Tesi

B

,

Davidsson

J

,

Voss

M

, et al.

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

.

Blood

.

2017

;

129

(

16

):

2266

-

2279

.

42.

Allenspach

EJ

,

Soveg

F

,

Finn

LS

, et al.

Germline SAMD9L truncation variants trigger global translational repression

.

J Exp Med

.

2021

;

218

(

5

):

e20201195

.

43.

Zhang

M

,

Yao

C

,

Cai

J

, et al.

LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production

.

J Transl Med

.

2019

;

17

(

1

):

37

.

44.

Allende

ML

,

Tuymetova

G

,

Lee

BG

,

Bonifacino

E

,

Wu

YP

,

Proia

RL

.

S1P1 receptor directs the release of immature B cells from bone marrow into blood

.

J Exp Med

.

2010

;

207

(

5

):

1113

-

1124

.

45.

Landreth

KS

,

Narayanan

R

,

Dorshkind

K

.

Insulin-like growth factor-I regulates pro-B cell differentiation

.

Blood

.

1992

;

80

(

5

):

1207

-

1212

.

46.

Clutter

SD

,

Fortney

J

,

Gibson

LF

.

MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis

.

Exp Hematol

.

2005

;

33

(

10

):

1192

-

1200

.

47.

Gatto

D

,

Brink

R

.

B cell localization: regulation by EBI2 and its oxysterol ligand

.

Trends Immunol

.

2013

;

34

(

7

):

336

-

341

.

48.

Gatto

D

,

Paus

D

,

Basten

A

,

Mackay

CR

,

Brink

R

.

Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses

.

Immunity

.

2009

;

31

(

2

):

259

-

269

.

49.

Moir

S

,

Buckner

CM

,

Ho

J

, et al.

B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy

.

Blood

.

2010

;

116

(

25

):

5571

-

5579

.

50.

Moir

S

,

Fauci

AS

.

Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease

.

J Allergy Clin Immunol

.

2008

;

122

(

1

):

12

-

19

. quiz 20-11.

51.

Tipton

TRW

,

Hall

Y

,

Bore

JA

, et al.

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic

.

Nat Commun

.

2021

;

12

(

1

):

1153

.

52.

Winslow

GM

,

Cooper

A

,

Reiley

W

,

Chatterjee

M

,

Woodland

DL

.

Early T-cell responses in tuberculosis immunity

.

Immunol Rev

.

2008

;

225

:

284

-

299

.

53.

Turka

LA

,

Linsley

PS

,

Lin

H

, et al.

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

.

Proc Natl Acad Sci U S A

.

1992

;

89

(

22

):

11102

-

11105

.

54.

Merli

P

,

Caruana

I

,

De Vito

R

, et al.

Role of interferon-gamma in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

.

Haematologica

.

2019

;

104

(

11

):

2314

-

2323

.

55.

Vinuesa

CG

,

Linterman

MA

,

Yu

D

,

MacLennan

IC

.

Follicular helper T cells

.

Annu Rev Immunol

.

2016

;

34

:

335

-

368

.

56.

Breitfeld

D

,

Ohl

L

,

Kremmer

E

, et al.

Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production

.

J Exp Med

.

2000

;

192

(

11

):

1545

-

1552

.

57.

Wong

CK

,

Wong

PT

,

Tam

LS

,

Li

EK

,

Chen

DP

,

Lam

CW

.

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity

.

J Clin Immunol

.

2010

;

30

(

1

):

45

-

52

.

58.

Moura

RA

,

Fonseca

JE

.

JAK inhibitors and modulation of B cell immune responses in rheumatoid arthritis

.

Front Med (Lausanne)

.

2020

;

7

:

607725

.

59.

Gabr

JB

,

Liu

E

,

Mian

S

, et al.

Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature

.

Ann Transl Med

.

2020

;

8

(

14

):

887

.

60.

Lo

MS

,

Zurakowski

D

,

Son

MB

,

Sundel

RP

.

Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study

.

Pediatr Rheumatol Online J

.

2013

;

11

(

1

):

42

.

61.

Granata

G

,

Didona

D

,

Stifano

G

,

Feola

A

,

Granata

M

.

Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature

.

Case Rep Med

.

2015

;

2015

:

294041

.

62.

Calame

KL

.

Plasma cells: finding new light at the end of B cell development

.

Nat Immunol

.

2001

;

2

(

12

):

1103

-

1108

.

63.

Nguyen

DC

,

Joyner

CJ

,

Sanz

I

,

Lee

FE

.

Factors affecting early antibody secreting cell maturation into long-lived plasma cells

.

Front Immunol

.

2019

;

10

:

2138

.

64.

Fairfax

KA

,

Kallies

A

,

Nutt

SL

,

Tarlinton

DM

.

Plasma cell development: from B-cell subsets to long-term survival niches

.

Semin Immunol

.

2008

;

20

(

1

):

49

-

58

.

65.

de Benedetti

F

,

Massa

M

,

Robbioni

P

,

Ravelli

A

,

Burgio

GR

,

Martini

A

.

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

.

Arthritis Rheum

.

1991

;

34

(

9

):

1158

-

1163

.

66.

Choy

EH

,

De Benedetti

F

,

Takeuchi

T

,

Hashizume

M

,

John

MR

,

Kishimoto

T

.

Translating IL-6 biology into effective treatments

.

Nat Rev Rheumatol

.

2020

;

16

(

6

):

335

-

345

.

67.

Enoksson

SL

,

Grasset

EK

,

Hagglof

T

, et al.

The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells

.

Proc Natl Acad Sci U S A

.

2011

;

108

(

51

):

E1399

-

1407

.

68.

Jego

G

,

Bataille

R

,

Pellat-Deceunynck

C

.

Interleukin-6 is a growth factor for nonmalignant human plasmablasts

.

Blood

.

2001

;

97

(

6

):

1817

-

1822

.

69.

Toubiana

J

,

Okada

S

,

Hiller

J

, et al.

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype

.

Blood

.

2016

;

127

(

25

):

3154

-

3164

.

70.

Chandrakasan

S

,

Chandra

S

,

Davila Saldana

BJ

,

Torgerson

TR

,

Buchbinder

D

.

Primary immune regulatory disorders for the pediatric hematologist and oncologist: a case-based review

.

Pediatr Blood Cancer

.

2019

;

66

(

5

):

e27619

.

71.

Kumar

D

,

Prince

C

,

Bennett

CM

, et al.

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

.

Blood

.

2022

;

139

(

3

):

369

-

383

.